SCOPUS 정보 검색 플랫폼

Volumn 120, Issue 6, 2001, Pages 1438-1447

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a

(8) Zeuzem, Stefan a Herrmann, Eva b Lee, Jung Hun a Fricke, Jens b Neumann, Avidan U c Modi, Marlene d Colucci, Giuseppe e Roth, W Kurt f

a UNIVERSITY HOSPITAL FRANKFURT (Germany)

b Bar llan University ^* (Germany)

c BAR ILAN UNIVERSITY (Israel)

d HOFFMANN LA ROCHE INC (United States)

e Hoffmann LaRoche (Switzerland)

f Inst Transfusionsmedizin I (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIREMIA; VIRUS REPLICATION;

EID: 0035050182 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/gast.2001.24006 Document Type: Article

Times cited : (269)

References (25)

1
- 0031567749
- Hepatitis C: Global prevalence
- (1997) Wkly Epidemiol Rec , vol.72 , pp. 341-344

2
- 0030933395
- Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
- (1997) Lancet , vol.349 , pp. 825-832
- Poynard, T.¹ Bedossa, P.² Opolon, P.³

3
- 0030885637
- Natural history of hepatitis C
- (1997) Hepatology , vol.26 , pp. 21S-28S
- Seeff, L.B.¹

4
- 15644380122
- Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy
- (1997) Ann Intern Med , vol.127 , pp. 875-881
- Marcellin, P.¹ Boyer, N.² Gervais, A.³ Martinot, M.⁴ Pouteau, M.⁵ Castelnau, C.⁶ Kilani, A.⁷ Areias, J.⁸ Auperin, A.⁹ Benhamou, J.P.¹⁰ Degott, C.¹¹ Erlinger, S.¹²

5
- 0032896077
- Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
- (1999) Semin Liver Dis , vol.19 , pp. 57-65
- McHutchison, J.G.¹ Poynard, T.²

6
- 0029833829
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
- (1996) Hepatology , vol.24 , pp. 778-789
- Poynard, T.¹ Leroy, V.² Cohard, M.³ Thevenot, T.⁴ Mathurin, P.⁵ Opolon, P.⁶ Zarski, J.P.⁷

7
- 0023620205
- Time course of interferon levels, antiviral state, 2′,5′-oligoadenylate synthetase and side effects in healthy men
- (1987) J Interferon Res , vol.7 , pp. 29-39
- Barouki, F.M.¹ Witter, F.R.² Griffin, D.E.³ Nadler, P.I.⁴ Woods, A.⁵ Wood, D.L.⁶ Lietman, P.S.⁷

8
- 0025203837
- Clinical pharmacokinetics of interferons
- (1990) Clin Pharmacokinet , vol.19 , pp. 390-399
- Wills, R.J.¹

9
- 0026124772
- The therapeutic value of poly-(ethylene glycol)-modified proteins
- (1991) Adv Drug Delivery Rev , vol.6 , pp. 133-151
- Nucci, M.L.¹ Shorr, R.² Abuchowski, A.³

10
- 0001299981
- A branched methoxy 40 kDa polyethylene glycol (PEG) moiety optimizes the pharmacokinetics (PK) of peginterferon α-2a (PEG-IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC)
- (1999) Hepatology , vol.30 , pp. 190A
- Algranati, N.E.¹ Sy, S.² Modi, M.³

11
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³ Heathcote, E.J.⁴ Lai, M.-Y.⁵ Gane, E.⁶ O'Grady, J.⁷ Reichen, J.⁸ Diago, M.⁹ Lin, A.¹⁰ Hoffman, J.¹¹ Brunda, M.J.¹²

12
- 0032475822
- Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
- (1998) Science , vol.282 , pp. 103-107
- Neumann, A.U.¹ Lam, N.P.² Dahari, H.³ Gretch, D.R.⁴ Wiley, T.E.⁵ Layden, T.J.⁶ Perelson, A.S.⁷

13
- 0030039045
- Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
- (1996) Hepatology , vol.23 , pp. 366-371
- Zeuzem, S.¹ Schmidt, J.M.² Lee, J.-H.³ Rüster, B.⁴ Roth, W.K.⁵

14
- 0029658282
- COBAS AMPLICOR: Fully automated RNA and DNA amplification and detection system for routine PCR
- (1996) Clin Chem , vol.42 , pp. 1915-1923
- DiDomenico, N.¹ Link, H.² Knobel, R.³ Caratsch, T.⁴ Weschler, W.⁵ Loewy, Z.G.⁶ Rosenstraus, M.⁷

15
- 0029958282
- Evaluation of automated COBAS AMPLICOR PCR system, for detection of several infectious agents and its impact on laboratory management
- (1996) J Clin Microbiol , vol.34 , pp. 2778-2783
- Jungkind, D.¹ DiRienzo, S.² Beavis, K.G.³ Silverman, N.S.⁴

16
- 0031918127
- Multicenter evaluation of COBAS AMPLICOR HCV, an integrated PCR system for the rapid detection of hepatitis C virus RNA in the diagnostic laboratory
- (1998) J Clin Microbiol , vol.36 , pp. 862-865
- Albadalejo, J.¹ Alonso, R.² Antinozzi, R.³ Bogard, M.⁴ Bourgault, A.M.⁵ Colucci, G.⁶ Fenner, T.⁷ Petersen, H.⁸ Sala, E.⁹ Vincelette, J.¹⁰ Young, C.¹¹

17
- 0032947751
- Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
- (1999) J Clin Microbiol , vol.37 , pp. 1567-1569
- Doglio, A.¹ Laffont, C.² Caroli-Bosc, F.X.³ Rochet, P.⁴ Lefebvre, J.⁵

18
- 0030988728
- Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays
- (1997) J Hepatol , vol.26 , pp. 1001-1009
- Lee, J.-H.¹ Roth, W.K.² Zeuzem, S.³

19
- 0031807791
- Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
- (1998) Hepatology , vol.28 , pp. 245-252
- Zeuzem, S.¹ Schmidt, J.M.² Lee, J.-H.³ Von Wagner, M.⁴ Teuber, G.⁵ Roth, W.K.⁶

20
- 0031009603
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
- (1997) Hepatology , vol.26 , pp. 226-231
- Lam, N.P.¹ Neumann, A.U.² Gretch, D.R.³ Wiley, T.E.⁴ Perelson, A.S.⁵ Layden, A.J.⁶

21
- 0033914625
- Differences in viral dynamics between genotype 1 and genotype 2 of hepatitis C virus
- (2000) J Infect Dis , vol.182 , pp. 28-35
- Neumann, A.U.¹ Lam, N.P.² Dahari, H.³ Davidian, M.⁴ Wiley, T.E.⁵ Perelson, A.S.⁶ Layden, T.J.⁷

22
- 0031924165
- Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
- (1998) Hepatology , vol.27 , pp. 1149-1156
- Zeuzem, S.¹ Lee, J.-H.² Franke, A.³ Rüster, B.⁴ Prümmer, O.⁵ Herrmann, G.⁶ Roth, W.K.⁷

23
- 0032501714
- Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C
- (1998) Lancet , vol.351 , pp. 83-87
- Reichard, O.¹ Norkrans, G.² Fryden, A.³ Braconier, J.H.⁴ Sonnerborg, A.⁵ Weiland, O.⁶

24
- 0000049360
- Early prediction and mechanism of the ribavirin/IFN-α dual therapy effect on chronic hepatitis C virus (HCV) infection
- (1999) Hepatology , vol.30 , pp. 309A
- Neumann, A.U.¹ Dahari, H.² Conrad, A.³ Pianko, S.⁴ McHutchison, J.G.⁵

25
- 0033884783
- Hepatitis C virus kinetics
- (2000) Antiviral Ther , vol.5 , pp. 85-90
- Herrmann, E.¹ Neumann, A.U.² Schmidt, J.M.³ Zeuzem, S.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.